| Autor: |
Winden, M.E.C., Haar, E.L.M., Groenewoud, J.M.M., Kerkhof, P.C.M., Jong, E.M.G.J., Lubeek, S.F.K. |
| Předmět: |
|
| Zdroj: |
British Journal of Dermatology; Apr2021, Vol. 184 Issue 4, p759-762, 4p |
| Abstrakt: |
Moreover, comorbidities and comedication could contribute to these patient preferences in those aiming to reduce medication use.8 Therefore, assessment of individual patient characteristics, QoL impact, treatment goals and preferences could facilitate decision making. Dear Editor, Psoriasis management in the rapidly expanding geriatric population can be complex owing to frailty, comorbidities, comedication and limited available data on treating older patients with psoriasis.1 Previous studies reported comparable disease severity in patients aged >= 65 years and patients aged < 65 years,2-4 although prescribed antipsoriatic therapies differed between age groups.2,3,5 This might be due to comorbidities and comedication, and/or disease perception or patient preferences.3,5 Unfortunately, little is known regarding these topics in older patients with psoriasis. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text